Agnostic Software for Monitoring and Control of Bioreactors

The National Institute for Innovation in Manufacturing Biopharmaceuticals, located in Delaware, is seeking a vendor to provide platform-agnostic software for the monitoring and control of bioreactors. The agency needs to enable machine-to-machine communication for most commercially available bioreactor systems with orchestrating systems and supporting devices. This software will allow the agency to conduct and monitor automated mammalian cell culture. The scope of work requires the creation of software compliant with OPC UA and companion specifications. The developed software must additionally support higher levels of interoperability through alignment with Industrial Ontologies Foundry and Allotrope semantic standards. The performance of this work will take place offsite. Eligibility is restricted to onshore United States organizations only. The agency is currently looking for proposals to determine the budget, and key dates are not specified in the initial announcement. Because the main request for proposals document is not publicly available on the website, the agency has provided these brief initial requirements to signal their current procurement needs.